Millipore "worth every Euro," says Merck CEO Kley

Merck KGaA CEO Karl-Ludwig Kley says following the late February announcement of the company's acquisition of biotech supplier Millipore, he was asked more than once if the $6 billion price was too high. "I have a clear answer: No, Millipore is worth every euro," he says, as quoted in BusinessWeek. He adds the takeover "will transform" Merck's life science chemicals division. Article

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.